Literature DB >> 31288251

Bridging clinic: The initial medical management of patients with newly diagnosed pancreatic cancer.

Loveena Sreedharan1, Bhaskar Kumar2, Anna Jewell3, Paul Banim4, Andreas Koulouris5, Andrew R Hart6.   

Abstract

Pancreatic cancer is the 11th most common cancer in the UK and has the worst prognosis of any tumour with minimal improvements in survival over recent decades. As most patients are either ineligible for surgery or may decline chemotherapy, the emphasis is on control of symptoms and management of complications such as poor nutritional status. The time period between informing the patient of their diagnosis and commencing cancer treatments presents a valuable opportunity to proactively identify and treat symptoms to optimise patients' overall well-being. The 'bridging clinic', delivered by a range of healthcare professionals from gastroenterologists to nurse practitioners, can provide this interface where patients are first informed of their diagnosis and second supportive therapies offered. In this article, we provide a structure for instituting such supportive therapies at the bridging clinic. The components of the clinic are summarised using the mnemonic INDASH (Information/Nutrition/Diabetes and Depression/Analgesia/Stenting/Hereditary) and each is discussed in detail below.

Entities:  

Keywords:  pancreatic cancer

Year:  2018        PMID: 31288251      PMCID: PMC6583575          DOI: 10.1136/flgastro-2018-101002

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  52 in total

1.  Is the Hospital Anxiety and Depression Scale (HADS) useful in assessing depression in palliative care?

Authors:  N Holtom; J Barraclough
Journal:  Palliat Med       Date:  2000-05       Impact factor: 4.762

2.  Effects of depression on the survival of pancreatic adenocarcinoma.

Authors:  Shahin Sheibani-Rad; Vic Velanovich
Journal:  Pancreas       Date:  2006-01       Impact factor: 3.327

3.  Vanilloids in pancreatic cancer: potential for chemotherapy and pain management.

Authors:  M Hartel; F F di Mola; F Selvaggi; G Mascetta; M N Wente; K Felix; N A Giese; U Hinz; P Di Sebastiano; M W Büchler; H Friess
Journal:  Gut       Date:  2005-09-20       Impact factor: 23.059

4.  Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients.

Authors:  P W Pisters; W A Hudec; K R Hess; J E Lee; J N Vauthey; S Lahoti; I Raijman; D B Evans
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

5.  Use of expandable metallic biliary stents in resectable pancreatic cancer.

Authors:  Sanjeev M Wasan; William A Ross; Gregg A Staerkel; Jeffrey H Lee
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

6.  Do preoperative biliary stents increase postpancreaticoduodenectomy complications?

Authors:  T A Sohn; C J Yeo; J L Cameron; H A Pitt; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

7.  Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases.

Authors:  Güralp O Ceyhan; Frank Bergmann; Mustafa Kadihasanoglu; Burak Altintas; Ihsan E Demir; Ulf Hinz; Michael W Müller; Thomas Giese; Markus W Büchler; Nathalia A Giese; Helmut Friess
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

8.  Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.

Authors:  Michael W Müller; Helmut Friess; Jörg Köninger; David Martin; Moritz N Wente; Ulf Hinz; Güralp O Ceyhan; Pavel Blaha; Jörg Kleeff; Markus W Büchler
Journal:  Am J Surg       Date:  2008-02       Impact factor: 2.565

Review 9.  Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions.

Authors:  Christian J Nelson; Nina Nandy; Andrew J Roth
Journal:  Palliat Support Care       Date:  2007-09

10.  The natural history of hereditary pancreatitis: a national series.

Authors:  V Rebours; M-C Boutron-Ruault; M Schnee; C Férec; C Le Maréchal; O Hentic; F Maire; P Hammel; P Ruszniewski; P Lévy
Journal:  Gut       Date:  2008-08-28       Impact factor: 23.059

View more
  2 in total

1.  Progressing pancreaticobiliary medicine in the UK.

Authors:  Andrew R Hart; Gavin Johnson; Matthew T Huggett
Journal:  Frontline Gastroenterol       Date:  2019-06-10

2.  Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus.

Authors:  A Carrato; L Cerezo; J Feliu; T Macarulla; E Martín-Pérez; R Vera; J Álvarez; J I Botella-Carretero
Journal:  Clin Transl Oncol       Date:  2021-08-07       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.